US Broker Ratings

Liquidia Corporation (LQDA) Stock Analysis: Exploring the 20% Upside Potential Amidst Groundbreaking Revenue Growth

Liquidia Corporation (NASDAQ: LQDA), a promising player in the biotechnology sector, has captured the attention of investors with its impressive revenue growth and potential upside. Based..

National HealthCare Corporation (NHC) Stock Analysis: Steady Revenue Growth Amidst Unrated Territory

National HealthCare Corporation (NYSE: NHC) operates within the healthcare sector, specializing in medical care facilities. With a market capitalization of $2.13 billion, the company is a..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 26.13% Potential Upside Amidst Challenging Metrics

Investors are taking a keen look at Neogen Corporation (NYSE: NEOG), a prominent player in the diagnostics and research industry with a focus on food and..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a 76.77% Potential Upside in the Biotech Sector

Investors with an eye on the healthcare sector may find Centessa Pharmaceuticals plc (NASDAQ: CNTA) an intriguing opportunity. This UK-based biotechnology company, with a market capitalization..

Immunocore Holdings plc (IMCR)

⚠️ No article content returned.

..

Enovis Corporation (ENOV) Stock Analysis: Exploring the Healthcare Innovator’s 89.63% Potential Upside

Enovis Corporation (NYSE: ENOV), a key player in the medical devices industry, has been catching the eyes of investors with its impressive potential upside of 89.63%...

Warby Parker Inc. (WRBY) Stock Analysis: Can This Eyewear Innovator Maintain Its 15.2% Revenue Growth?

Warby Parker Inc. (NYSE: WRBY) has emerged as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. Best known for..

Tarsus Pharmaceuticals (TARS) Stock Analysis: A Promising Biotech Player with a 23% Upside Potential

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a biopharmaceutical company dedicated to eye care innovation, is garnering significant attention from investors. With a market capitalization of $3.02 billion,..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Biotech Star with 14.83% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is drawing significant attention in the biotechnology sector, promising innovative treatments for chronic diseases while showcasing an impressive market trajectory. With..

Beam Therapeutics Inc. (BEAM): Investor Outlook with a 44.78% Potential Upside

Beam Therapeutics Inc. (NASDAQ: BEAM), a Cambridge, Massachusetts-based biotechnology company, is capturing investor attention with its innovative approach to precision genetic medicines. Despite the challenges inherent..

IDEAYA Biosciences (IDYA) Stock Analysis: A Promising Upside of 38.69% in Precision Medicine

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a prominent player in the biotechnology sector, is making waves with its innovative approach to precision medicine oncology. With a market..

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Navigating Potential Upside in the Medical Devices Market

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands as a noteworthy player in the healthcare sector, specifically within the medical devices industry. With its headquarters in San..

Mesoblast Limited (MESO) Stock Analysis: 100% Upside Potential in Biotech Breakthrough

Mesoblast Limited (MESO), an Australian biotechnology company, is capturing the attention of investors with a staggering potential upside of 100.57%. Specializing in regenerative medicine, Mesoblast is..

Indivior PLC (INDV) Investor Outlook: A 35.66% Potential Upside with Strong Buy Ratings

Indivior PLC (INDV), a prominent player in the healthcare sector, is capturing significant investor attention with its robust position in the drug manufacturing industry, particularly in..

Clover Health Investments, Corp (CLOV) Stock Analysis: Unpacking a 27.3% Potential Upside

For investors eyeing the healthcare sector, Clover Health Investments, Corp (NASDAQ: CLOV) presents a mix of challenges and opportunities. With a market capitalization of $1.31 billion,..

AtriCure, Inc. (ATRC) Stock Analysis: A Promising 35% Upside Potential Amid Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC), a key player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing investment opportunity for those seeking exposure..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Strong Buy Ratings and 50% Potential Upside

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company focused on rare kidney and metabolic diseases, has become a compelling point of interest for investors, showcasing a..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 6.43% Potential Upside in a Dynamic Healthcare Landscape

Bausch Health Companies Inc. (BHC), a prominent player in the healthcare sector, operates a diversified portfolio that spans specialty pharmaceuticals and medical devices. With a market..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Biotech Gem with a 27.70% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE), a rising star in the biotechnology sector, is captivating investor attention with its promising pipeline and a substantial upside potential of..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Growth in Senior Care with a 7.58% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, is making waves in the medical care facilities industry with its robust portfolio..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds